Moffitt logo

COVID-19 Update: See new visitor policy effective Jan. 3. Learn More

Clinical Trials Search

Clinical Trial 21240

Cancer Type: Malignant Hematology
Study Type: Treatment
NCT#:

Phase: Phase III
Prinicipal Investigator: Deutsch, Yehuda

Call 813-745-6100
or 1-800-679-0775 Learn More
Overview

Study Title

An open label, multi-center Phase IIIb study of asciminib (ABL001) monotherapy in previously treated patients with chronic myeloid leukemia in chronic phase (CML-CP) with and without T315I mutation (AIM4CML)

Summary

Objective

Treatments

Therapies

Medications

If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.